Alexion Pharmaceuticals - 24 Year Stock Price History | ALXN

Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Alexion Pharmaceuticals as of July 07, 2020 is 112.46.
  • The all-time high Alexion Pharmaceuticals stock closing price was 207.84 on July 23, 2015.
  • The Alexion Pharmaceuticals 52-week high stock price is 125.52, which is 11.6% above the current share price.
  • The Alexion Pharmaceuticals 52-week low stock price is 72.67, which is 35.4% below the current share price.
  • The average Alexion Pharmaceuticals stock price for the last 52 weeks is 105.52.
Alexion Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 102.5125 107.8400 119.9000 75.5600 112.4600 3.99%
2019 118.1113 98.0500 141.3000 94.8400 108.1500 11.08%
2018 120.0025 124.0500 139.0100 93.9400 97.3600 -18.59%
2017 125.7262 122.6300 146.6900 97.7000 119.5900 -2.26%
2016 134.8574 184.6800 184.9000 110.0100 122.3500 -35.86%
2015 177.6471 186.6000 207.8400 145.6000 190.7500 3.09%
2014 166.7312 133.4400 200.7900 129.8200 185.0300 39.24%
2013 104.9874 100.0500 132.9100 83.3900 132.8840 41.76%
2012 94.2987 70.5700 118.1500 70.2900 93.7400 31.10%
2011 53.8780 40.6650 71.5500 40.6650 71.5000 77.53%
2010 29.1347 24.1250 41.1700 22.7500 40.2750 64.99%
2009 20.1819 18.0650 24.4100 15.8250 24.4100 34.90%
2008 18.1343 18.8775 23.7525 12.7425 18.0950 -3.53%
2007 13.6236 10.1525 19.9500 8.9425 18.7575 85.76%
2006 8.7138 5.0725 11.3500 5.0150 10.0975 99.46%
2005 6.0305 6.0925 7.4975 4.6550 5.0625 -19.64%
2004 4.9553 4.3125 6.3750 3.3925 6.3000 48.15%
2003 3.8358 3.6250 5.2300 2.5850 4.2525 20.47%
2002 4.0792 5.7750 6.5650 2.3950 3.5300 -42.23%
2001 6.3246 15.3900 18.6875 3.7375 6.1100 -62.37%
2000 17.8134 7.3750 29.0750 6.9375 16.2350 115.53%
1999 3.2124 3.1250 7.8450 2.1095 7.5325 125.19%
1998 2.7282 2.9700 3.7500 1.5000 3.3450 7.04%
1997 2.7061 2.1875 3.8450 2.0313 3.1250 43.84%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $25.079B $4.991B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $150.738B 16.60
Bristol Myers Squibb (BMY) United States $136.191B 11.38
Gilead Sciences (GILD) United States $96.286B 12.48
CSL (CSLLY) Australia $92.372B 0.00
Vertex Pharmaceuticals (VRTX) United States $75.530B 51.93
Regeneron Pharmaceuticals (REGN) United States $69.009B 26.60
Illumina (ILMN) United States $55.770B 57.31
Biogen (BIIB) United States $44.028B 7.54
Seattle Genetics (SGEN) United States $29.505B 0.00
Incyte (INCY) United States $23.431B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.095B 209.36
Genmab (GMAB) Denmark $22.365B 18.42
Moderna (MRNA) United States $21.958B 0.00
Genmab (GNMSF) Denmark $21.042B 62.47
Alnylam Pharmaceuticals (ALNY) United States $17.584B 0.00
BeiGene (BGNE) Cayman Islands $15.299B 0.00
BioNTech SE (BNTX) Germany $14.822B 0.00
Exact Sciences (EXAS) United States $13.345B 0.00
Galapagos (GLPG) Belgium $13.216B 38.88
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Sarepta Therapeutics (SRPT) United States $12.750B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.086B 27.28
ARGENX SE-ADR (ARGX) Netherlands $11.082B 0.00
Bio-Techne Corp (TECH) United States $10.314B 68.14
QIAGEN (QGEN) Netherlands $9.853B 28.65
Immunomedics (IMMU) United States $9.381B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.368B 0.00
Guardant Health (GH) United States $8.062B 0.00
Ascendis Pharma (ASND) Denmark $7.288B 0.00
Exelixis (EXEL) United States $7.096B 24.88
Repligen (RGEN) United States $6.621B 116.14
Adaptive Biotechnologies (ADPT) United States $5.960B 0.00
Acceleron Pharma (XLRN) United States $5.463B 0.00
Reata Pharmaceuticals (RETA) United States $5.332B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.212B 112.15
Ultragenyx Pharmaceutical (RARE) United States $5.175B 0.00
Mirati Therapeutics (MRTX) United States $5.078B 0.00
Vir Biotechnology (VIR) United States $4.836B 0.00
Zai Lab (ZLAB) China $4.782B 0.00
Novavax (NVAX) United States $4.604B 0.00
Emergent Biosolutions (EBS) United States $4.497B 29.47
MorphoSys AG (MOR) Germany $4.341B 33.67
MyoKardia (MYOK) United States $4.306B 0.00
Blueprint Medicines (BPMC) United States $4.298B 0.00
China Biologic Products (CBPO) China $4.176B 23.22
Global Blood Therapeutics (GBT) United States $4.116B 0.00
Amicus Therapeutics (FOLD) United States $4.020B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.877B 0.00
Halozyme Therapeutics (HALO) United States $3.801B 0.00
NeoGenomics (NEO) United States $3.660B 267.31
Inovio Pharmaceuticals (INO) United States $3.309B 0.00
Bluebird Bio (BLUE) United States $3.232B 0.00
Arena Pharmaceuticals (ARNA) United States $3.197B 0.00
Alkermes (ALKS) Ireland $3.116B 61.34
Deciphera Pharmaceuticals (DCPH) United States $3.076B 0.00
Insmed (INSM) United States $2.897B 0.00
Fate Therapeutics (FATE) United States $2.859B 0.00
Denali Therapeutics (DNLI) United States $2.694B 0.00
Amarin (AMRN) Ireland $2.691B 0.00
PHARMA MAR SA (PHMMF) Spain $2.379B 0.00
Viela Bio (VIE) United States $2.254B 0.00
UniQure (QURE) Netherlands $1.986B 0.00
Twist Bioscience (TWST) United States $1.913B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.906B 0.00
Principia Biopharma (PRNB) United States $1.893B 0.00
Eidos Therapeutics (EIDX) United States $1.884B 0.00
Ligand Pharmaceuticals (LGND) United States $1.827B 71.14
Alector (ALEC) United States $1.800B 0.00
Editas Medicine (EDIT) United States $1.694B 0.00
Zymeworks (ZYME) Canada $1.690B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.683B 0.00
Adverum Biotechnologies (ADVM) United States $1.643B 0.00
Epizyme (EPZM) United States $1.598B 0.00
I-Mab (IMAB) China $1.567B 0.00
Intra-Cellular Therapies (ITCI) United States $1.565B 0.00
Mesoblast (MESO) Australia $1.531B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.519B 0.00
Beam Therapeutics (BEAM) United States $1.515B 0.00
Sorrento Therapeutics (SRNE) United States $1.502B 0.00
Revance Therapeutics (RVNC) United States $1.494B 0.00
Mersana Therapeutics (MRSN) United States $1.487B 0.00
Zealand Pharma (ZEAL) Denmark $1.472B 0.00
Cytokineticsorporated (CYTK) United States $1.448B 0.00
Akcea Therapeutics (AKCA) United States $1.428B 0.00
Sangamo Therapeutics (SGMO) United States $1.385B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
REGENXBIO (RGNX) United States $1.349B 0.00
Arvinas (ARVN) United States $1.329B 0.00
NGM Biopharmaceuticals (NGM) United States $1.295B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.232B 0.00
NantKwest (NK) United States $1.168B 0.00
Intellia Therapeutics (NTLA) United States $1.156B 0.00
Athenex (ATNX) United States $1.114B 0.00
Arcus Biosciences (RCUS) United States $1.106B 0.00
Compugen (CGEN) Israel $1.058B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.957B 0.00
Alcobra (ARCT) United States $0.946B 0.00
Retrophin (RTRX) United States $0.887B 0.00
Myriad Genetics (MYGN) United States $0.884B 45.62
Heska (HSKA) United States $0.866B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Pharming Group (PHGUF) Netherlands $0.826B 22.00
Cara Therapeutics (CARA) United States $0.822B 0.00
Cellectis S.A (CLLS) France $0.809B 0.00
Morphic Holding (MORF) United States $0.790B 0.00
Intrexon (PGEN) United States $0.787B 0.00
Dynavax Technologies (DVAX) United States $0.781B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.748B 0.00
Kadmon Holdings (KDMN) United States $0.733B 0.00
Codexis (CDXS) United States $0.731B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.692B 0.00
Castle Biosciences (CSTL) United States $0.684B 0.00
Frequency Therapeutics (FREQ) United States $0.683B 0.00
Vericel (VCEL) United States $0.668B 123.33
Agenus (AGEN) United States $0.663B 0.00
Cue Biopharma (CUE) United States $0.641B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.641B 5.49
Sinovac Biotech (SVA) China $0.640B 20.87
VBI Vaccines (VBIV) United States $0.639B 0.00
AnaptysBio (ANAB) United States $0.606B 0.00
MiMedx (MDXG) United States $0.597B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.576B 0.00
Kala Pharmaceuticals (KALA) United States $0.575B 0.00
NextCure (NXTC) United States $0.564B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.551B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Anika Therapeutics (ANIK) United States $0.541B 17.41
Syndax Pharmaceuticals (SNDX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.532B 0.00
Athersys (ATHX) United States $0.529B 0.00
Syros Pharmaceuticals (SYRS) United States $0.524B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.520B 0.00
UROGEN PHARMA (URGN) United States $0.520B 0.00
Scholar Rock Holding (SRRK) United States $0.509B 0.00
Clovis Oncology (CLVS) United States $0.502B 0.00
Protagonist Therapeutics (PTGX) United States $0.495B 0.00
DBV Technologies S.A (DBVT) France $0.495B 0.00
AC Immune SA (ACIU) Switzerland $0.464B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.462B 0.00
MeiraGTx Holdings (MGTX) United States $0.455B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
BioDelivery Sciences (BDSI) United States $0.449B 23.60
Geron (GERN) United States $0.433B 0.00
Precision BioSciences (DTIL) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.426B 0.00
Puma Biotechnology (PBYI) United States $0.422B 0.00
Avid Bioservices (CDMO) United States $0.397B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.395B 0.00
Albireo Pharma (ALBO) United States $0.395B 0.00
ANI Pharmaceuticals (ANIP) United States $0.379B 7.52
Kamada (KMDA) Israel $0.377B 15.67
CytomX Therapeutics (CTMX) United States $0.377B 0.00
MannKind (MNKD) United States $0.371B 0.00
Seres Therapeutics (MCRB) United States $0.370B 0.00
WAVE Life Sciences (WVE) Singapore $0.348B 0.00
OSMOTICA PHARM (OSMT) United States $0.345B 0.00
PDL BioPharma (PDLI) United States $0.341B 293.00
Affimed (AFMD) Germany $0.331B 0.00
Prometic Life Sciences (LMNL) Canada $0.321B 0.00
Cellular Biomedicine (CBMG) United States $0.320B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Celldex Therapeutics (CLDX) United States $0.284B 0.00
Pfenex (PFNX) United States $0.284B 0.00
Spero Therapeutics (SPRO) United States $0.284B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.284B 0.00
Menlo Therapeutics (MNLO) United States $0.277B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.274B 0.00
Verastem (VSTM) United States $0.262B 0.00
Abeona Therapeutics (ABEO) United States $0.260B 0.00
IVERIC Bio (ISEE) United States $0.260B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.260B 0.00
Northwest Biotherapeutics (NWBO) United States $0.252B 0.00
Gritstone Oncology (GRTS) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Selecta Biosciences (SELB) United States $0.240B 0.00
HOOKIPA Pharma (HOOK) United States $0.237B 0.00
IBio (IBIO) United States $0.237B 0.00
Dyadic (DYAI) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.225B 0.00
Liquidia Technologies (LQDA) United States $0.224B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
XOMA (XOMA) United States $0.222B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Exicure (XCUR) United States $0.218B 0.00
Aptinyx (APTX) United States $0.216B 0.00
GENFIT S.A (GNFT) France $0.207B 0.00
Aduro Biotech (ADRO) United States $0.207B 0.00
Strongbridge Biopharma (SBBP) United States $0.207B 0.00
Bellus Health (BLU) Canada $0.205B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Sutro Biopharma (STRO) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.191B 0.00
Trevena (TRVN) United States $0.184B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.169B 0.00
Aytu Bioscience (AYTU) United States $0.165B 0.00
Cyclerion Therapeutics (CYCN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.159B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Theratechnologies (THTX) Canada $0.157B 0.00
Cerecor (CERC) United States $0.154B 0.00
Applied Genetic Technologies (AGTC) United States $0.152B 0.00
VolitionRX (VNRX) United States $0.151B 0.00
Biofrontera AG (BFRA) Germany $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.129B 0.00
Celsion (CLSN) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.120B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
AIT Therapeutics (XAIR) United States $0.119B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.99
Eton Pharmaceuticals (ETON) United States $0.113B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
AquaBounty Technologies (AQB) United States $0.103B 0.00
DiaMedica Therapeutics (DMAC) United States $0.100B 0.00
Windtree Therapeutics (WINT) United States $0.097B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Cardiff Oncology (CRDF) United States $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.077B 0.00
AnPac Bio-Medical Science (ANPC) China $0.076B 0.00
Catalyst Biosciences (CBIO) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Happiness Biotech Group (HAPP) China $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Unum Therapeutics (UMRX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Signal Genetics (MGEN) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.039B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00